Neogenomics Inc
NEO8.620USD
+0.510+6.29%
Handelsschluss 09/18, 16:00（ET）Kurse um 15 Minuten verzögert
1.11BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Neogenomics Inc Unternehmen
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.
Unternehmensinformationen
BörsenkürzelNEO
Name des UnternehmensNeogenomics Inc
IPO-datumDec 10, 2012
CEOMr. Antony P. Zook
Anzahl der mitarbeiter2200
WertpapierartOrdinary Share
GeschäftsjahresendeDec 10
Addresse9490 Neogenomics Way
StadtFORT MYERS
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl33912
Telefon12397680600
Websitehttps://neogenomics.com/
BörsenkürzelNEO
IPO-datumDec 10, 2012
CEOMr. Antony P. Zook
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
186.66K
+12.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. Antony P. Zook
Mr. Antony P. Zook
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
186.66K
+12.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
Aktionärsstatistik
Aktualisiert: Fri, Aug 15
Aktualisiert: Fri, Aug 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.76%
The Vanguard Group, Inc.
10.92%
Greenhouse Funds LLLP
5.75%
First Light Asset Management, LLC
5.30%
State Street Global Advisors (US)
3.96%
Andere
60.32%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.76%
The Vanguard Group, Inc.
10.92%
Greenhouse Funds LLLP
5.75%
First Light Asset Management, LLC
5.30%
State Street Global Advisors (US)
3.96%
Andere
60.32%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
50.14%
Investment Advisor/Hedge Fund
31.89%
Hedge Fund
14.04%
Research Firm
2.36%
Individual Investor
1.29%
Pension Fund
1.17%
Bank and Trust
0.61%
Sovereign Wealth Fund
0.09%
Family Office
0.05%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
571
126.82M
98.17%
-12.95M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
2023Q2
691
121.76M
95.45%
-23.63M
2023Q1
704
120.14M
94.21%
-27.80M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
18.29M
14.21%
-356.84K
-1.91%
Mar 31, 2025
The Vanguard Group, Inc.
14.23M
11.06%
+17.23K
+0.12%
Mar 31, 2025
Greenhouse Funds LLLP
4.71M
3.66%
+6.43K
+0.14%
Mar 31, 2025
First Light Asset Management, LLC
6.04M
4.7%
+2.88M
+90.77%
Mar 31, 2025
State Street Global Advisors (US)
5.09M
3.95%
-109.12K
-2.10%
Mar 31, 2025
Macquarie Investment Management
4.68M
3.63%
+864.39K
+22.67%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.85M
2.99%
+408.27K
+11.88%
Mar 31, 2025
Schroder Investment Management North America Inc.
4.31M
3.35%
+509.99K
+13.42%
Mar 31, 2025
American Century Investment Management, Inc.
3.32M
2.58%
+426.34K
+14.74%
Mar 31, 2025
Millennium Management LLC
6.72M
5.22%
+5.29M
+371.20%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
